- Home
- SCWO vs ALGS Comparison
SCWO vs ALGS Comparison
Compare SCWO & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCWO | ALGS |
|---|---|---|
| Founded | 2021 | 2018 |
| Country | United States | United States |
| Employees | N/A | 70 |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 49.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SCWO | ALGS |
|---|---|---|
| Price | $3.15 | $8.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $46.67 |
| AVG Volume (30 Days) | ★ 156.1K | 80.4K |
| Earning Date | 11-12-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,910,340.00 | ★ $2,646,000.00 |
| Revenue This Year | $5,945.19 | N/A |
| Revenue Next Year | $106.82 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 508.52 | N/A |
| 52 Week Low | $1.63 | $3.76 |
| 52 Week High | $10.90 | $29.54 |
Technical Indicators
Market Signals| Indicator | SCWO | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 66.92 | 42.99 |
| Support Level | $2.93 | $7.92 |
| Resistance Level | $3.50 | $9.13 |
| Average True Range (ATR) | 0.32 | 0.81 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 65.69 | 21.98 |
Price Performance
Historical ComparisonAbout SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.